BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11811935)

  • 1. Maternal immune stimulation in mice decreases fetal malformations caused by teratogens.
    Holladay SD; Sharova LV; Punareewattana K; Hrubec TC; Gogal RM; Prater MR; Sharov AA
    Int Immunopharmacol; 2002 Feb; 2(2-3):325-32. PubMed ID: 11811935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonspecific stimulation of the maternal immune system. I. Effects On teratogen-induced fetal malformations.
    Holladay SD; Sharova L; Smith BJ; Gogal RM; Ward DL; Blaylock BL
    Teratology; 2000 Dec; 62(6):413-9. PubMed ID: 11091363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diverse ability of maternal immune stimulation to reduce birth defects in mice exposed to teratogens: a review.
    Hrubec TC; Prater MR; Mallela MK; Gogal RM; Guo TL; Holladay SD
    J Dev Orig Health Dis; 2012 Jun; 3(3):132-9. PubMed ID: 25102004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonspecific stimulation of the maternal immune system. II. Effects on gene expression in the fetus.
    Sharova L; Sura P; Smith BJ; Gogal RM; Sharov AA; Ward DL; Holladay SD
    Teratology; 2000 Dec; 62(6):420-8. PubMed ID: 11091364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placental improvement and reduced distal limb defects by maternal interferon-gamma injection in methylnitrosourea-exposed mice.
    Laudermilch CL; Holladay SD; Sponenberg DP; Saunders GK; Ward DL; Prater MR
    Birth Defects Res A Clin Mol Teratol; 2005 Sep; 73(9):597-604. PubMed ID: 16080182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced birth defects caused by maternal immune stimulation in methylnitrosourea-exposed mice: association with placental improvement.
    Prater MR; Zimmerman KL; Ward DL; Holladay SD
    Birth Defects Res A Clin Mol Teratol; 2004 Nov; 70(11):862-9. PubMed ID: 15526292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prebreeding maternal immunostimulation with Freund's complete adjuvant reduces placental damage and distal limb defects caused by methylnitrosourea.
    Renee Prater M; Zimmerman KL; Laudermilch CL; Holladay SD
    Am J Reprod Immunol; 2006 Feb; 55(2):145-55. PubMed ID: 16433834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune stimulation in urethane-exposed pregnant mice increases expression level of spleen leukocyte genes for TGFbeta3 GM-CSF and other cytokines that may play a role in reduced chemical-induced birth defects.
    Sharova LV; Gogal RM; Sharov AA; Chrisman MV; Holladay SD
    Int Immunopharmacol; 2002 Sep; 2(10):1477-89. PubMed ID: 12400877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid-induced fetal malformations are reduced by maternal immune stimulation with granulocyte-macrophage colony-stimulating factor or interferon-gamma.
    Hrubec TC; Yan M; Ye K; Salafia CM; Holladay SD
    Anat Rec A Discov Mol Cell Evol Biol; 2006 Dec; 288(12):1303-9. PubMed ID: 17075842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Ipomoea carnea and BCG reduces birth defects caused by cyclophosphamide in rats.
    Latorre AO; Hueza IM; Górniak SL
    Life Sci; 2007 Jan; 80(5):430-5. PubMed ID: 17070555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in diabetes-induced craniofacial defects by maternal immune stimulation.
    Hrubec TC; Prater MR; Toops KA; Holladay SD
    Birth Defects Res B Dev Reprod Toxicol; 2006 Feb; 77(1):1-9. PubMed ID: 16342200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal immune stimulation reduces both placental morphologic damage and down-regulated placental growth-factor and cell cycle gene expression caused by urethane: are these events related to reduced teratogenesis?
    Sharova LV; Sharov AA; Sura P; Gogal RM; Smith BJ; Holladay SD
    Int Immunopharmacol; 2003 Jul; 3(7):945-55. PubMed ID: 12810352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiteratogenic effects of alpha-naphthoflavone on 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposed mice in utero.
    Jang JY; Shin S; Choi BI; Park D; Jeon JH; Hwang SY; Kim JC; Kim YB; Nahm SS
    Reprod Toxicol; 2007; 24(3-4):303-9. PubMed ID: 17889503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
    Ornoy A
    Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced birth defects caused by maternal immune stimulation may involve increased expression of growth promoting genes and cytokine GM-CSF in the spleen of diabetic ICR mice.
    Punareewattana K; Sharova LV; Li W; Ward DL; Holladay SD
    Int Immunopharmacol; 2003 Nov; 3(12):1639-55. PubMed ID: 14555289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiteratogenic effect of resveratrol in mice exposed in utero to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Jang JY; Park D; Shin S; Jeon JH; Choi BI; Joo SS; Hwang SY; Nahm SS; Kim YB
    Eur J Pharmacol; 2008 Sep; 591(1-3):280-3. PubMed ID: 18571640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malformation spectrum induced by ketoconazole after single administration to pregnant rats during the critical period - comparison with vitamin A-induced malformation spectrum.
    Mineshima H; Fukuta T; Kato E; Uchida K; Aoki T; Matsuno Y; Mori C
    J Appl Toxicol; 2012 Feb; 32(2):98-107. PubMed ID: 21319175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of diabetes-induced palate defects by maternal immune stimulation.
    Hrubec TC; Toops KA; Holladay SD
    Anat Rec (Hoboken); 2009 Feb; 292(2):271-6. PubMed ID: 19089897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC-associated immunopotentiation affects the embryo response to teratogens.
    Torchinsky A; Fein A; Carp HJ; Toder V
    Clin Exp Immunol; 1994 Dec; 98(3):513-9. PubMed ID: 7994915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase-specific developmental toxicity in mice following maternal methanol inhalation.
    Bolon B; Dorman DC; Janszen D; Morgan KT; Welsch F
    Fundam Appl Toxicol; 1993 Nov; 21(4):508-16. PubMed ID: 8253303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.